I Have Breast Cancer

Lymphedema

“I’ve often heard people talk about lymphedema. What is it?”

Dr. Anna Towers, director of the lymphedema program at the McGill University Health Centre, explains.

Lymphedema is characterized by localized fluid retention and painful tissue swelling and is brought on by a compromised lymphatic system. It is a risk for all patients undergoing cancer surgery and radiotherapy but especially breast cancer patients.  Often taking years to manifest itself, lymphedema is devastating to cancer patients who have already suffered the ravages of one disease, only to be made susceptible to another chronic debilitating condition. Those with uncontrolled lymphedema are subject to recurrent bacterial infections (cellulities) of the affected limb, requiring hospitalizations. 

Lymphedema and related arm and shoulder problems should be diagnosed as early as possible as this will increase the effectiveness of the current recommended treatment, Complete Decongestive Therapy (CDT). CDT aims to improve lymph drainage through existing lymphatic vessels and to encourage collateral circulation. It can be subdivided into two treatment phases:

1- an edema reduction phase of approximately 1 month for those with greater degrees of lymphedema. This treatment involves specific massage techniques (manual lymphatic drainage) and application of special bandages.

2- a maintenance phase, which is a life-long commitment to wearing a compression garment during the day and to performing special exercises.

There are now more than 60 qualified therapists in this province who provide the treatment mostly privately.

Since lymphedema is incurable, prevention initiatives and patient education are critical for early diagnosis. Province-wide awareness programs are a key component of the Quebec Breast Cancer Foundation Lymphedema Support Centre

To learn more about lymphedema, please visit:

Lymphedema Association of Québec
McGill Lymphedema Research Program